HOME >> BIOLOGY >> NEWS
Setting the real bottom line: Dr. David Suzuki to speak at ESA annual meeting

On Wednesday, August 9, 2000 at 8:30 p.m. Dr. David Suzuki, award-winning scientist, environmentalist, and broadcaster, will speak at the public plenary session of the Ecological Society of America's 85th Annual Meeting. This year's meeting will be held in Snowbird, Utah August 6-10. In an address entitled "The Ecological Millennium: Setting the Real Bottom Line" Dr. Suzuki will discuss the importance of ecology in today's rapidly changing world.

In addition to his achievements as a scientist, Dr. David Suzuki has received consistently high acclaim for his thirty years of award-winning work in broadcasting. His talent for explaining the complexities of science in a compelling and easily understood way has made his television and radio series popular among scientists and non-scientists alike. He is perhaps best known for his eight-part PBS series The Secret of Life and his five-part Discovery Channel series The Brain. Additionally, Dr. Suzuki is the host of the Canadian Broadcasting Corporation's popular science television series, The Nature of Things. He also initiated the CBC's long running radio series Quirks and Quacks.

Much of Dr. Suzuki's work occurs through the projects and campaigns of the David Suzuki Foundation (http://www.davidsuzuki.org). Dr. Suzuki will discuss his efforts to prevent ecological crises and find ways for humans to live in balance with nature. He primarily focuses his energies within two comprehensive project areas: Climate Change and Pacific Salmon Forests. The first campaign is designed to educate the public, government and business leaders about the urgency and practical strategies for reducing global warming caused by human activities. The second project works toward a broad, economically and ecologically sound vision of Canada's northwest coast that conserves the rare and important coastal temperate rainforest.

Dr. Suzuki is a geneticist with a B.S. degree from Am
'"/>

Contact: Alison Gillespie
alison@esa.org
202-833-8773 ext. 21
Ecological Society of America
4-Jul-2000


Page: 1 2

Related biology news :

1. Setting the gene expression base-line for breast cancer research
2. Setting the evolutionary record straight
3. Setting the stage for limb development
4. Walleye fishery threatened; Puerto Rico aquaculture, calling ALVIN on ocean bottom
5. Big-bottomed sheep have a rare genetic mutation that builds muscle, not fat
6. Researchers find glass-eating microbes at the rock bottom of the food chain
7. Mercury at bottom of central park lake linked to coal burning in NYC
8. Analysis of impact studies reveals how bottom fishing affects seafloor denizens
9. Writing in Nature, scientists identify genes key to differentiating top from bottom in plant leaves
10. A big whoop! Crane chicks will hatch on-line: Go to whoopers.USGS.gov
11. David Rosmarin wins 2004 Sarber Award from American Society for Microbiology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Setting the real bottom line David Suzuki speak ESA annual meeting

(Date:8/12/2015)... YORK , Aug. 12, 2015  New ... hackers can attack Android phones to steal users, ... the increasing availability of fingerprint scanners on mobile ... utmost concern. To secure biometrics on mobile devices, ... to augment these convenient authentication systems with strong ...
(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cbgl72/middle_east_and ) has announced the ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Middle East & Africa Biomedical Sensors ... a CAGR of 3.26% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/31/2015)... Aug. 31, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... the 30-day review period following the filing of ... indications with the U.S. Food and Drug Administration ... active. Logo -  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:8/31/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 31, 2015 ... on the discovery and development of novel cancer immunotherapies, ... , M.D., Ph.D., as Chief Executive Officer and ... Drs. Wong and Ho join an experienced management team ... company: Jordan Fridman , Ph.D., Chief Scientific Officer; ...
(Date:8/31/2015)... ... 31, 2015 , ... Regulatory agencies have acknowledged impurities especially ... process. Thus, innovator companies must understand what will be needed in the drug ... been hosting multiple educational panels and seminars for experts to share advice concerning ...
Breaking Biology Technology:Middle East & Africa Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts to 2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3
Cached News: